R. A. Sacher

1.2k total citations
24 papers, 770 citations indexed

About

R. A. Sacher is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, R. A. Sacher has authored 24 papers receiving a total of 770 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 7 papers in Immunology and 3 papers in Genetics. Recurrent topics in R. A. Sacher's work include Hematopoietic Stem Cell Transplantation (8 papers), T-cell and Retrovirus Studies (3 papers) and Mesenchymal stem cell research (3 papers). R. A. Sacher is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), T-cell and Retrovirus Studies (3 papers) and Mesenchymal stem cell research (3 papers). R. A. Sacher collaborates with scholars based in United States, Canada and Switzerland. R. A. Sacher's co-authors include Edward L. Murphy, John W. Engstrom, Joy Fridey, William R. Vogler, Robert Abels, Thomas H. Price, George Garratty, Bruce Newman, Joan Gibble and James W. Smith and has published in prestigious journals such as Neurology, British Journal of Cancer and Transfusion.

In The Last Decade

R. A. Sacher

24 papers receiving 733 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. A. Sacher United States	15	343	276	176	172	159	24	770
Janet Sutherland United Kingdom	15	184 0.5×	262 0.9×	24 0.1×	211 1.2×	21 0.1×	24	637
D.A.F. Chamone Brazil	14	72 0.2×	222 0.8×	23 0.1×	26 0.2×	20 0.1×	43	506
Y Tsuji Japan	14	192 0.6×	90 0.3×	103 0.6×	4 0.0×	93 0.6×	30	489
Yasutaka Kakinoki Japan	12	107 0.3×	154 0.6×	11 0.1×	71 0.4×	19 0.1×	43	444
W. Craig Hooper United States	15	192 0.6×	123 0.4×	68 0.4×	3 0.0×	59 0.4×	34	522
E. Sanna Italy	11	57 0.2×	73 0.3×	24 0.1×	14 0.1×	9 0.1×	38	433
Seiko Kato Japan	14	142 0.4×	420 1.5×	14 0.1×	7 0.0×	12 0.1×	80	691
S Yokomaku Japan	11	148 0.4×	372 1.3×	17 0.1×	4 0.0×	24 0.2×	23	611
Y Suen United States	17	569 1.7×	347 1.3×	4 0.0×	9 0.1×	4 0.0×	24	1.1k
Jan Wesche Germany	15	147 0.4×	358 1.3×	3 0.0×	71 0.4×	3 0.0×	47	694

Countries citing papers authored by R. A. Sacher

Since Specialization

Citations

This map shows the geographic impact of R. A. Sacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. A. Sacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. A. Sacher more than expected).

Fields of papers citing papers by R. A. Sacher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. A. Sacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. A. Sacher. The network helps show where R. A. Sacher may publish in the future.

Co-authorship network of co-authors of R. A. Sacher

This figure shows the co-authorship network connecting the top 25 collaborators of R. A. Sacher. A scholar is included among the top collaborators of R. A. Sacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. A. Sacher. R. A. Sacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biswas, Hope H., John W. Engstrom, Zhanna Kaidarova, et al.. (2009). Neurologic abnormalities in HTLV-I– and HTLV-II–infected individuals without overt myelopathy. Neurology. 73(10). 781–789. 47 indexed citations

Crookston, Kendall P., Alex P. Reiner, Laurence J.N. Cooper, et al.. (2000). RBC T activation and hemolysis: implications for pediatric transfusion management. Transfusion. 40(7). 801–812. 44 indexed citations

Sacher, R. A.. (1999). Thrombophilia: a genetic predisposition to thrombosis.. PubMed. 110. 51–60; discussion 60. 5 indexed citations

Murphy, Edward L., Joy Fridey, James W. Smith, et al.. (1997). HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. Neurology. 48(2). 315–320. 102 indexed citations

Cahill, Ronan A., et al.. (1997). Interleukin-2-activated hematopoietic stem cell transplantation for breast cancer: investigation of dose level with clinical correlates. Bone Marrow Transplantation. 20(8). 643–651. 22 indexed citations

Price, Thomas H., Lawrence T. Goodnough, William R. Vogler, et al.. (1996). The effect of recombinant human erythropoietin on the efficacy of autologous blood donation in patients with low hematocrits: a multicenter, randomized, double‐blind, controlled trial. Transfusion. 36(1). 29–36. 64 indexed citations

Verma, Udit, et al.. (1996). Hematopoietic potential of IL-2-cultured peripheral blood stem cells from breast cancer patients.. PubMed. 18(3). 521–5. 20 indexed citations

Sacher, R. A., et al.. (1996). An improved method of encapsulation of doxorubicin in liposomes: pharmacological, toxicological and therapeutic evaluation. British Journal of Cancer. 74(1). 43–48. 54 indexed citations

Spitzer, Thomas R., et al.. (1994). The Impact of Harvest Center on Quality of Marrows Collected from Unrelated Donors. Journal of Hematotherapy. 3(1). 65–70. 9 indexed citations

10.

Sloand, Elaine M., Pallavi Kumar, Harvey G. Klein, Sharon L. Merritt, & R. A. Sacher. (1994). Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection. Transfusion. 34(1). 48–53. 46 indexed citations

11.

Goodnough, Lawrence T., Thomas H. Price, Kenneth D. Friedman, et al.. (1994). A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacy. Transfusion. 34(1). 66–71. 98 indexed citations

12.

Spitzer, Thomas R., et al.. (1993). Use of a licensed electrolyte solution as an alternative to tissue culture medium for bone marrow collection. Transfusion. 33(7). 562–566. 6 indexed citations

13.

Spitzer, Thomas R., Michele Cottler‐Fox, Patrick S. Sullivan, et al.. (1992). Continuous infusion intravenous immunoglobulin is associated with a reduced incidence of infection and achieves higher serum immunoglobulin G levels than intermittent infusion following bone marrow transplantation.. PubMed. 29(3 Suppl 2). 123–6. 4 indexed citations

14.

Spitzer, Thomas R., et al.. (1991). Automated processing of human bone marrow can result in a population of mononuclear cells capable of achieving engraftment following transplantation. Transfusion. 31(8). 724–730. 15 indexed citations

15.

Sacher, R. A., et al.. (1990). Effective ultraviolet irradiation of platelet concentrates in teflon bags. Transfusion. 30(8). 678–681. 25 indexed citations

16.

Sacher, R. A., R. G. Strauss, N. L. C. Luban, et al.. (1990). Blood component therapy during the neonatal period: a national survey of red cell transfusion practice, 1985. Transfusion. 30(3). 271–276. 16 indexed citations

17.

Strauss, Ronald G., R. A. Sacher, Victor S. Blanchette, et al.. (1990). Commentary on small‐volume red cell transfusions for neonatal patients. Transfusion. 30(6). 565–570. 31 indexed citations

18.

Blanchette, Victor S., R. A. Sacher, Penny Ballem, J B Bussel, & Paul Imbach. (1989). Commentary on the management of autoimmune thrombocytopenia during pregnancy and in the neonatal period. Annals of Hematology. 59(1). 121–123. 2 indexed citations

19.

Sacher, R. A. & Jeffrey C. King. (1989). Perinatal diagnosis of passive ITP: Use of percutaneous umbilical blood sampling (PUBS). Annals of Hematology. 59(1). 128–131. 2 indexed citations

20.

Sacher, R. A., et al.. (1989). A hospital-wide blind control program for bedside glucose meters.. PubMed. 113(12). 1370–5. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact